Synapse News

9 of 33

Ontario Together Fund Supports NERv Technology’s Domestic Manufacturing

hrough the Ontario Together Fund, the Ontario provincial government has committed $559,200 to support the domestic manufacturing and commercialization of NERv Technology’s breakthrough post-operative monitoring solutions as part of the company’s $1.118 million investment. NERv Technology Inc. is a Kitchener-based medical device…

April 29, 2022 | Alex Muggah

$20 million investment will improve access to high-quality care for families in Hamilton

Ontario Building a Stronger, More Resilient Hamilton Health Sciences As part of its plan stay open, the Ontario government is investing over $20 million to modernize Hamilton Health Sciences. This funding will support planning for the redevelopment of Juravinski Hospital and Cancer Centre and the expansion of Hamilton General Hospital’s…

April 22, 2022 | Alex Muggah

Two Hamilton innovators win national Arthritis Ideator Awards

Two Hamiltonians were among 4 winners (and eight finalists) in a national competition which provides funding for innovative projects that help people suffering from arthritis. The Arthritis Ideator Program — run by the Arthritis Society — received 21 submissions from innovators, entrepreneurs, and startups across Canada working on…

April 21, 2022 | Alex Muggah

McMaster Seed Fund supports two startups in first round of funding with $735,000

Two McMaster startups – Syndemix and Insight Medbotics – have received a combined  $735,000 to move their innovations closer to reality in the first round of investments of the McMaster Seed Fund. Synmedix — a biotechnology company founded by Eric Brown, Distinguished University Professor of biochemistry and biomedical sciences —…

April 20, 2022 | Alex Muggah

Ontario invests $40 million to grow global life sciences sector at Hamilton’s McMaster Innovation Park

Hamilton could become the “catalyst” that will see Ontario become a global hub for biomanufacturing and life sciences growth. Invest Ontario is providing OmniaBio Inc. with about $40 million in a loan as part of a new $580-million biomanufacturing facility at McMaster Innovation Park on Longwood Road. The goal for the Ontario government…

April 4, 2022 | Alex Muggah

Ontario economic development minister Announces $40M investment in Hamilton’s OmniaBio (video)

Vic Fedeli, Minister of Economic Development, Job Creation and Trade, was joined by Prabmeet Sarkaria, President of the Treasury Board, and Donna Skelly, MPP for Flamborough—Glanbrook, to make an announcement at McMaster Innovation Park

March 31, 2022 | Alex Muggah

Invest Ontario Supports New Biomanufacturing Facility in Hamilton

Invest Ontario is supporting OmniaBio Inc. in launching a new biomanufacturing facility that will catalyze Ontario life sciences jobs and innovation while advancing pioneering medicine with the potential to cure, not just treat, many forms of cancer, cardiovascular diseases, Parkinson’s and diabetes. OmniaBio, a Canadian cell and gene…

March 31, 2022 | Alex Muggah

New gene- and cell-therapy manufacturing facility to launch in Hamilton with $580-million commitment

Ontario says it will provide a $40-million loan to the Centre for Commercialization of Regenerative Medicine for its planned $580-million Hamilton facility where life-science companies can develop and commercialize cell and gene therapies. The CCRM, a non-profit industry group, said Thursday that the facility will be run by a new subsidiary…

March 31, 2022 | Alex Muggah

Triumvira Immunologics Completes Extension of Series A Financing, for Total Round of Approximately $100 Million

Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells to treat patients with solid tumors, today announced the completion of an extension of its Series A financing, bringing the total round to approximately $100 million. The Series A…

March 17, 2022 | Alex Muggah